Company Registration No. 10819323 (England and Wales)
HEALTH DISPENSE PROPERTY COMPANY LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025
PAGES FOR FILING WITH REGISTRAR
HEALTH DISPENSE PROPERTY COMPANY LIMITED
CONTENTS
Page
Accountants' report
1
Statement of financial position
2
Statement of changes in equity
3
Notes to the financial statements
4 - 9
HEALTH DISPENSE PROPERTY COMPANY LIMITED
COMPANY INFORMATION
Directors
Mr R Patel
Mr H Shah
Company number
10819323
Registered office
83-85 Baker Street
London
W1U 6AG
Accountants
King and King
83-85 Baker Street
London
W1U 6AG
Bankers
Lloyds Bank
1 Market Square
Aylesbury
Buckinghamshire
HP20 1TD
HEALTH DISPENSE PROPERTY COMPANY LIMITED
ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF HEALTH DISPENSE PROPERTY COMPANY LIMITED FOR THE YEAR ENDED 31 AUGUST 2025
- 1 -
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Health Dispense Property Company Limited for the year ended 31 August 2025 which comprise, the statement of financial position, the statement of changes in equity and the related notes from the company’s accounting records and from information and explanations you have given us.
As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at https://www.icaew.com/regulation.
This report is made solely to the board of directors of Health Dispense Property Company Limited, as a body, in accordance with the terms of the engagement letter dated 7 July 2017. Our work has been undertaken solely to prepare for your approval the financial statements of Health Dispense Property Company Limited and state those matters that we have agreed to state to the board of directors of Health Dispense Property Company Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Health Dispense Property Company Limited and its board of directors as a body, for our work or for this report.
It is your duty to ensure that Health Dispense Property Company Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of Health Dispense Property Company Limited. You consider that Health Dispense Property Company Limited is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the financial statements of Health Dispense Property Company Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
King and King
Chartered Accountants
83-85 Baker Street
London
W1U 6AG
21 May 2026
HEALTH DISPENSE PROPERTY COMPANY LIMITED
STATEMENT OF FINANCIAL POSITION
AS AT
31 AUGUST 2025
31 August 2025
- 2 -
2025
2024
Notes
£
£
£
£
Non-current assets
Investment properties
4
1,589,000
1,646,059
Current assets
Trade and other receivables
5
720
1,629
Cash and cash equivalents
9,820
556
10,540
2,185
Current liabilities
6
(673,458)
(643,219)
Net current liabilities
(662,918)
(641,034)
Total assets less current liabilities
926,082
1,005,025
Non-current liabilities
7
(894,958)
(921,380)
Net assets
31,124
83,645
Equity
Called up share capital
100
100
Retained earnings
31,024
83,545
Total equity
31,124
83,645
The directors of the company have elected not to include a copy of the income statement within the financial statements.true
For the financial year ended 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved by the board of directors and authorised for issue on 21 May 2026 and are signed on its behalf by:
Mr R Patel
Director
Company Registration No. 10819323
HEALTH DISPENSE PROPERTY COMPANY LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 AUGUST 2025
- 3 -
Share capital
Retained earnings
Total
£
£
£
Balance at 1 September 2023
100
80,698
80,798
Year ended 31 August 2024:
Profit and total comprehensive income for the year
-
2,847
2,847
Balance at 31 August 2024
100
83,545
83,645
Year ended 31 August 2025:
Loss and total comprehensive income for the year
-
(52,521)
(52,521)
Balance at 31 August 2025
100
31,024
31,124
HEALTH DISPENSE PROPERTY COMPANY LIMITED
STATEMENT OF CHANGES IN EQUITY (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
- 4 -
1
Judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
2
Accounting policies
Company information
Health Dispense Property Company Limited is a private company limited by shares incorporated in England and Wales. The registered office is 83-85 Baker Street, London, W1U 6AG. . The Company registration number is 10819323.
2.1
Basis of preparation
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.
The company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the company as an individual entity and not about its group.
2.2
Going concern
Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
Revenue is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business, and is shown net of VAT and other sales related taxes.
The company recognises revenue from the following major sources:
The nature, timing of satisfaction of performance obligations and significant payment terms of the company's major sources of revenue are as follows:
HEALTH DISPENSE PROPERTY COMPANY LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025
2
Accounting policies
(Continued)
- 5 -
Rental income
Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that it is probable will be recovered.
2.3
Investment property
Investment property, which is property held to earn rentals and/or for capital appreciation, is initially recognised at cost, which includes the purchase cost and any directly attributable expenditure. Subsequently it is measured at fair value at the reporting end date. Changes in fair value are recognised in profit or loss.
The directors' are of the opinion that the market value of the leasehold property is not materially different from cost and is shown at a fair value.
2.4
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
2.5
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include trade and other receivables and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
HEALTH DISPENSE PROPERTY COMPANY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
2
Accounting policies
(Continued)
- 6 -
Basic financial liabilities
Basic financial liabilities, including trade and other payables, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade payables are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade payables are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
2.6
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
2.7
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
2.8
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or non-current assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
HEALTH DISPENSE PROPERTY COMPANY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
2
Accounting policies
(Continued)
- 7 -
2.9
Leases
As lessor
When the company acts as a lessor, a lease is classified as a finance lease whenever it transfers substantially all the risks and rewards of ownership of the underlying asset to the lessee, either at the end of the lease term or for the major part of the economic life of the asset. All other leases are classified as operating leases. If an arrangement contains both lease and non-lease components, the company allocates the consideration in the contract to the two elements.
Rental income from operating leases is recognised on a straight line basis over the term of the relevant lease. Initial direct costs incurred in negotiating and arranging an operating lease are added to the carrying amount of the leased asset and recognised on a straight line basis over the lease term.
2.10
Foreign exchange
Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.
3
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2025
2024
Number
Number
Total
0
0
4
Investment property
2025
£
Fair value
At 1 September 2024
1,646,059
Revaluations
(57,059)
At 31 August 2025
1,589,000
Investment property comprises £1,589,000. The fair value of the investment property has been arrived at on the basis of a valuation carried out at 31.08.2025 by the directors. The valuation was made on an open market value basis by reference to market evidence of transaction prices for similar properties.
5
Trade and other receivables
2025
2024
Amounts falling due within one year:
£
£
Other receivables
720
1,629
HEALTH DISPENSE PROPERTY COMPANY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
- 8 -
6
Current liabilities
2025
2024
£
£
Bank loans
17,644
17,359
Trade payables
296
966
Amounts owed to group undertakings
632,963
616,534
Corporation tax
1,065
667
Other payables
21,490
7,693
673,458
643,219
7
Non-current liabilities
2025
2024
£
£
Bank loans
894,958
921,380
The banks have several mortgage debentures creating a fixed and floating charge over the company. The charge also covers the property 3-5 Clive Parade, Northwood.
Creditors which fall due after five years are as follows:
2025
2024
£
£
Payable by instalments
824,384
851,945
8
Related party transactions
Transactions with related parties
During the year the company entered into the following transactions with related parties:
The Company has taken advantage of the exemptions available under FRS 102 Section 33.1A and as a results has not disclosed within the financial statements’ details of transactions with group members, undertaken during the year.
2025
2024
Amounts due to related parties
£
£
Entities with control, joint control or significant influence over the company
632,963
616,534
9
Parent company
The company is a fully owned subsidiary of Health Dispense Limited, a company incorporated in England and Wales.
HEALTH DISPENSE PROPERTY COMPANY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
9
Parent company
(Continued)
- 9 -
The ultimate controlling party is Mr R B Patel.
2025-08-312024-09-01falsefalsefalse21 May 2026CCH SoftwareCCH Accounts Production 2026.100No description of principal activityMr R PatelMr H Shah108193232024-09-012025-08-3110819323bus:Director12024-09-012025-08-3110819323bus:Director22024-09-012025-08-3110819323bus:RegisteredOffice2024-09-012025-08-3110819323bus:Agent12024-09-012025-08-31108193232025-08-31108193232024-08-3110819323core:CurrentFinancialInstruments2025-08-3110819323core:CurrentFinancialInstruments2024-08-3110819323core:Non-currentFinancialInstruments2025-08-3110819323core:Non-currentFinancialInstruments2024-08-3110819323core:ShareCapital2025-08-3110819323core:ShareCapital2024-08-3110819323core:RetainedEarningsAccumulatedLosses2025-08-3110819323core:RetainedEarningsAccumulatedLosses2024-08-3110819323core:ShareCapital2023-08-3110819323core:RetainedEarningsAccumulatedLosses2023-08-3110819323core:RetainedEarningsAccumulatedLosses2023-09-012024-08-31108193232023-09-012024-08-3110819323core:RetainedEarningsAccumulatedLosses2024-09-012025-08-31108193232024-08-3110819323core:CurrentFinancialInstrumentscore:WithinOneYear2025-08-3110819323core:CurrentFinancialInstrumentscore:WithinOneYear2024-08-3110819323core:EntitiesWithJointControlOrSignificantInfluenceOverReportingEntity2025-08-3110819323bus:PrivateLimitedCompanyLtd2024-09-012025-08-3110819323bus:SmallCompaniesRegimeForAccounts2024-09-012025-08-3110819323bus:FRS1022024-09-012025-08-3110819323bus:AuditExemptWithAccountantsReport2024-09-012025-08-3110819323bus:FullAccounts2024-09-012025-08-31xbrli:purexbrli:sharesiso4217:GBP